Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone
dc.authorid | Ulugol, Ahmet/0000-0003-4643-1124 | |
dc.authorwosid | Ulugol, Ahmet/V-9665-2019 | |
dc.contributor.author | Elmas, Pinar | |
dc.contributor.author | Ulugol, Ahmet | |
dc.date.accessioned | 2024-06-12T10:59:39Z | |
dc.date.available | 2024-06-12T10:59:39Z | |
dc.date.issued | 2013 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Cannabinoid CB1 receptors have been implicated in the antinociceptive effect of paracetamol. In the current study, we examined whether blockade of CB1 receptors prevent the analgesic activity of dipyrone, in a similar way to paracetamol. Hot-plate and tail-flick tests were used to assess the antinociceptive activity in mice. Dipyrone and WIN 55,212-2, a cannabinoid agonist, exerted significant antinociceptive effects in both hot-plate and tail flick tests. The CB1 receptor antagonist, AM-251 (3 mg/kg), at a dose which had no effect when used alone, did not alter the antinociceptive effect of dipyrone, whereas completely prevented the antinociceptive activity of WIN 55,212-2 in both thermal antinociceptive tests. Our findings suggest that, unlike paracetamol, cannabinoid CB1 receptors do not participate in the antinociceptive action of dipyrone when acute pain tests used. | en_US |
dc.description.sponsorship | Trakya University Research Council [TUBAP-2012/58] | en_US |
dc.description.sponsorship | This work was supported by a grant from Trakya University Research Council (TUBAP-2012/58). The authors have no conflicts of interests to report. | en_US |
dc.identifier.doi | 10.1007/s00702-013-1052-7 | |
dc.identifier.endpage | 1538 | en_US |
dc.identifier.issn | 0300-9564 | |
dc.identifier.issn | 1435-1463 | |
dc.identifier.issue | 11 | en_US |
dc.identifier.pmid | 23784345 | en_US |
dc.identifier.scopus | 2-s2.0-84887244709 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 1533 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s00702-013-1052-7 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/20518 | |
dc.identifier.volume | 120 | en_US |
dc.identifier.wos | WOS:000326054900003 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Wien | en_US |
dc.relation.ispartof | Journal Of Neural Transmission | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Dipyrone | en_US |
dc.subject | WIN 55,212-2 | en_US |
dc.subject | CB1 Receptor | en_US |
dc.subject | Antinociception | en_US |
dc.subject | Pag-Microinjected Dipyrone | en_US |
dc.subject | Endogenous Opioids | en_US |
dc.subject | Spinal-Cord | en_US |
dc.subject | Rvm Axis | en_US |
dc.subject | Metamizol | en_US |
dc.subject | Rats | en_US |
dc.subject | Mice | en_US |
dc.subject | Pain | en_US |
dc.subject | Paracetamol | en_US |
dc.subject | Activation | en_US |
dc.title | Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone | en_US |
dc.type | Article | en_US |